BACKGROUND: Amino acids (AA) activate the mammalian target of rapamycin (mTOR) signaling pathway but overactivation has a negative feedback effect on insulin signaling which may lead to insulin resistance and type 2 diabetes (T2DM). PURPOSE: To determine the effect of reduced AA concentrations on mTOR and insulin signaling during increased nutrient and insulin availability. METHODS: Six control and six T2DM subjects were studied at baseline and following a 5h AA lowering high energy and insulin clamp. Stable isotopic techniques in combination with femoral catheterizations were used to measure AA kinetics across the leg while muscle biopsies were used to measure mTOR and insulin signaling proteins using immunoblotting techniques. RESULTS: AA concentrations decreased by approximately 30-60% in both groups (p<0.05). Phospho-mTOR, S6K1, eEF2, and eIF2alpha were unchanged in both groups following the clamp (p>0.05). In T2DM subjects, IRS-1 serine phosphorylation was unchanged while phospho-AMPKalpha decreased and phospho-Akt, phospho-AS160 and glucose uptake increased following the clamp (p<0.05). In comparison, AA concentrations were maintained in a separate group during an insulin infusion. In this group, phospho-Akt, mTOR and S6K1 (n=4) increased. CONCLUSION: Amino acids are necessary for insulin-induced activation of mTOR signaling and protein synthesis in both healthy and insulin resistant skeletal muscle.
BACKGROUND: Amino acids (AA) activate the mammalian target of rapamycin (mTOR) signaling pathway but overactivation has a negative feedback effect on insulin signaling which may lead to insulin resistance and type 2 diabetes (T2DM). PURPOSE: To determine the effect of reduced AA concentrations on mTOR and insulin signaling during increased nutrient and insulin availability. METHODS: Six control and six T2DM subjects were studied at baseline and following a 5h AA lowering high energy and insulin clamp. Stable isotopic techniques in combination with femoral catheterizations were used to measure AA kinetics across the leg while muscle biopsies were used to measure mTOR and insulin signaling proteins using immunoblotting techniques. RESULTS: AA concentrations decreased by approximately 30-60% in both groups (p<0.05). Phospho-mTOR, S6K1, eEF2, and eIF2alpha were unchanged in both groups following the clamp (p>0.05). In T2DM subjects, IRS-1serine phosphorylation was unchanged while phospho-AMPKalpha decreased and phospho-Akt, phospho-AS160 and glucose uptake increased following the clamp (p<0.05). In comparison, AA concentrations were maintained in a separate group during an insulin infusion. In this group, phospho-Akt, mTOR and S6K1 (n=4) increased. CONCLUSION: Amino acids are necessary for insulin-induced activation of mTOR signaling and protein synthesis in both healthy and insulin resistant skeletal muscle.
Authors: Michael Krebs; Martin Krssak; Elisabeth Bernroider; Christian Anderwald; Attila Brehm; Martin Meyerspeer; Peter Nowotny; Erich Roth; Werner Waldhäusl; Michael Roden Journal: Diabetes Date: 2002-03 Impact factor: 9.461
Authors: Sung Hee Um; Francesca Frigerio; Mitsuhiro Watanabe; Frédéric Picard; Manel Joaquin; Melanie Sticker; Stefano Fumagalli; Peter R Allegrini; Sara C Kozma; Johan Auwerx; George Thomas Journal: Nature Date: 2004-08-11 Impact factor: 49.962
Authors: Pamela M J O'Connor; Scot R Kimball; Agus Suryawan; Jill A Bush; Hanh V Nguyen; Leonard S Jefferson; Teresa A Davis Journal: Am J Physiol Endocrinol Metab Date: 2003-03-11 Impact factor: 4.310
Authors: Nathan Hodson; Daniel W D West; Andrew Philp; Nicholas A Burd; Daniel R Moore Journal: Am J Physiol Cell Physiol Date: 2019-08-28 Impact factor: 4.249
Authors: Paul T Reidy; Dillon K Walker; Jared M Dickinson; David M Gundermann; Micah J Drummond; Kyle L Timmerman; Christopher S Fry; Michael S Borack; Mark B Cope; Ratna Mukherjea; Kristofer Jennings; Elena Volpi; Blake B Rasmussen Journal: J Nutr Date: 2013-01-23 Impact factor: 4.798
Authors: Micah J Drummond; Erin L Glynn; Christopher S Fry; Shaheen Dhanani; Elena Volpi; Blake B Rasmussen Journal: J Nutr Date: 2009-10-14 Impact factor: 4.798
Authors: Nicolas Smadja-Lamère; Michael Shum; Paul Déléris; Philippe P Roux; Jun-Ichi Abe; André Marette Journal: J Biol Chem Date: 2013-09-13 Impact factor: 5.157
Authors: Kim M Huffman; Svati H Shah; Robert D Stevens; James R Bain; Michael Muehlbauer; Cris A Slentz; Charles J Tanner; Maragatha Kuchibhatla; Joseph A Houmard; Christopher B Newgard; William E Kraus Journal: Diabetes Care Date: 2009-06-05 Impact factor: 19.112